
Carigent closes its $2mm Series A round
Executive Summary
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
Drug Delivery
- Controlled Release
- Macromolecule
- Site Specific
-
Biotechnology
- Antisense, Oligonucleotides
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com